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Abstract Analytical techniques for the determination of
polychorinated dibenzo-p-dioxins (PCDD), polychlori-
nated dibenzofurans (PCDF) and dioxin-like PCBs
(DLPCB) are reviewed. The focus of the review is on
recent advances in methodology and analytical procedures.
The paper also reviews toxicology, the development of
toxic equivalent factors (TEF) and the determination of
toxic equivalent quantity (TEQ) values. Sources, occur-
rence and temporal trends of PCDD/PCDF are summarized
to provide examples of levels and concentration ranges for
the methods and techniques reviewed.
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Introduction
In this review, we describe the current state-of-the-art for
the determination of the chlorinated dibenzo-p-dioxins
(dioxins), chlorinated dibenzofurans (furans), and dioxin-
like polychlorinated biphenyls (DLPCBs, or coplanar
PCBs). Only a brief summary of the historical development
of methods for these compounds is given here; all of the
most important earlier work has been summarized in
previous reviews [1–4].
The characteristics of modern methods for dioxin/furan/
DLPCB determination are derived from several factors
related to their chemical, physical and toxicological
properties. The exceptionally high toxicity of 2,3,7,8-
tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) meant from
the outset that very low detection limits (DLs) were
required; consideration of their hydrophobic nature and
concern over chronic rather than acute toxicity effects
meant that bioaccumulation was of increased concern,
which pushed the need for even lower DLs. An under-
standing of the environmental levels, transport and fate of
these compounds is important if we wish to understand the
significance of these compounds as well as the low
detection limits and broad range of detection required;
therefore, a section on levels, transport and fate of these
compounds is included in this review. Avariety of different
analytical methods and techniques have been developed to
increase sensitivity and selectivity and to reduce analysis
times. To fully understand the analytical methods devel-
oped and their application, the references cited in Table 5
should be examined. Table 5 also illustrates the wide range
of sample types and concentration ranges of dioxins and
DLPCBs detected in the global environment, which
explains why so many variations on the basic analytical
methodology exist.
Another factor in method development and application
was the large amount of litigation that occurred because of
the detection of these compounds in humans as well as the
environment. Methods of analysis were required to
generate data that could withstand scrutiny in a court of
law, which led to the necessity of using methods based on
isotope dilution–HRMS techniques. In addition, the rapid
growth in high-quality standards and reference materials
contributed to substantial improvements in the accuracy
and precision of modern methods.
The development of analytical methods was also
influenced by the need for regulators to be able to evaluate
the combined toxicity of a number of compounds that have
similar toxic properties to 2,3,7,8-TCDD, but widely
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development of analytical methods that we have included a
section below on toxicology and TEFs. The bottom line for
dioxin methods was that definitive separation of the
2,3,7,8-substituted dioxins/furans and DLPCBs from a
large number of other congeners with almost identical
physical and chemical properties, as well as numerous
other potentially interfering compounds, was essential.
Brief background on dioxin determination
Chlorinated dibenzo-p-dioxins (dioxins) have been of
concern for decades because of their toxic properties, as
described below. A structurally similar series of com-
pounds, the chlorinated dibenzofurans (furans), have
similar chemical properties and toxic effects, and are
generally determined as a group with the dioxins. In recent
years there has been a growing trend to include a specific
subgroup of the polychlorinated biphenyls (PCBs): the so-
called dioxin-like PCBs (DLPCBs). This has been added to
methods along with the dioxins and furans. Figure 1 shows
the structures of 2,3,7,8-TCDD, 2,3,7,8-TCDF and PCB-
126. The carbon numbering system is marked next to each
carbon to indicate substitution positions. Dioxin and furan
congeners substituted in the 2,3,7 or 8 position are toxic,
while PCBs substituted in the 3,3′,4,4′,5 or 5′ position and
no or only one 2- or 2′-substitution are considered to be
dioxin-like and to exhibit dioxin toxicity (see Table 1).
Originally, attention was focused on the most toxic
member of these substances, 2,3,7,8-TCDD. Gas chro-
matographic columns were soon developed that could
separate 2,3,7,8-TCDD from the other 21 TCDD isomers
in sample extracts [5], and other columns that could
fortuitously separate the groups of congeners from each
other by degree of chlorination (i.e., all tetrachlorinated
dioxins/furans were eluted, followed by all of the
pentachlorinated dioxins/furans, followed by the hexa-
chlorinated, then the heptachlorinated, then the octachlori-
nated [6]. Many early publications reported a so-called
congener group determination, where the total concentra-
tions of all of the isomers from each group containing the
same number of substituent chlorines were quantified and
summed. Under this approach, 11 concentrations would be
reported: total tetrachlorinated dioxins (T4CDDs), total
pentachlorinated dioxins (P5CDDs), total hexachlorinated
dioxins (H6CDDs), total heptachlorinated dioxins
(H7CDDs), the octachlorinated dioxin (OCDD), the same
dibenzofuran groups (T4CDFs, P5CDFs, H6CDFs,
H7CDFs, OCDF), and 2,3,7,8-TCDD. This type of deter-
mination is often incorrectly termed a total homolog
determination. Although “homolog” is still used today to
refer to dioxins or furans that have different numbers of
chlorine atom substituents, the chlorinated dioxin or furan
series are not homologous, because the different members
of the series are not formed by adding the same structural
unit (Cl atom), but by substituting Cl for H in higher
members of these series. The various chlorinated dioxins
are correctly termed “congeners” (members of a like
series), as are the chlorinated dibenzofurans.
It was clear over 30 years ago that gas chromatography–
mass spectrometry (GC–MS) was the instrumental method
of choice for dioxin and furan determinations. The great
tunable selectivity of mass spectrometry achieved by the
ability to monitor specific characteristic ions in the mass
spectrum of a compound combined with the retention time-
matching ability of a gas chromatogram made GC–MS far
superior to other detection systems. Even with the use of
GC–MS, the exceptionally great toxicity of 2,3,7,8-TCDD
meant that equally exceptionally low detection limits were
required for this compound in real environmental samples.
At such DLs as parts-per-trillion (ppt:10
−12 g 2,3,7,8-
TCDD perg of sample) or parts-per-quadrillion (ppq: 10
−15 g
2,3,7,8-TCDD per g of sample), the principal barrier to
Fig. 1 Basic structures of the chlorinated dibenzo-p-dioxins
(dioxins), chlorinated dibenzofurans (furans) and polychlorinated
biphenyls (PCBs). For the dioxins and furans, congeners with
chlorine substitution at the 2,3,7 and 8 positions are considered
toxic. Of the 75 possible dioxin and 135 possible furan structures,
only 17 have 2,3,7,8-substitution
792successful analysis of samples was the separation of TCDD
from the bulk sample matrix and from all other organic
chemicals in the matrix. The keys to success in this endeavor
were the number of separation steps in the entire analytical
scheme, and their effectiveness. These separation steps
included the following:
– Representative sampling (not included in this review);
– Separation of TCDD from the sample matrix (extrac-
tion); transfer of TCDD to an appropriate organic
solvent;
– Separation of TCDD from all other organic coex-
tractives (clean-up; can involve several distinct steps);
– Separation of TCDD from other relatively nontoxic
tetrachlorinated dioxin isomers (gas chromatography);
– Separation and recording of characteristic TCDD
molecular fragments using a mass spectrometer.
Although an impressive degree of optimization of each
of these steps has occurred over the past decade, this basic
approach was formulated in the mid-1970s. A paper
published in 1973 showed how high-resolution mass
spectrometry (HRMS) was used to determine 2,3,7,8-
TCDD in various sample types at the 1.0 ppt DL [7].
Modern dioxin/furan determination
In recent years, methods have built on the early develop-
ments referred to above, and have achieved a high degree
of sophistication and greatly improved accuracy and
precision. The various stages of development of dioxin/
furan determination can be generically described as
follows:
1970s to 1980s The principal concern was to ensure
correct identification of TCDD; the majority of analyses
reported total concentrations of dioxin and furan (tetra-
chlorinated to octachlorinated) congener groups, and/or
2,3,7,8-TCDD; very few reliable analytical standards or
certified reference materials were available; few labora-
tories worldwide could perform this work;
1980s to 1990s Fused silica open tubular GC columns
predominantly used for this application; quality control for
GC–MS methods enhanced greatly by the use of the
isotope-dilution technique; GC-HRMS was accepted as
“gold standard” method; introduction of “toxic equivalent
factors (TEFs)” made it imperative to improve speciation
of all dioxins/furans with chlorine substitution at the 2,3,7
Table 1 World Health Organization toxic equivalent factors (TEFs) for humans/mammals, fish and birds [37]
Congener Humans/Mammals Fish Birds
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) 1 1 1
1,2,3,7,8-Pentachlorodibenzo-p-dioxin (PeCDD) 1 1 1
1,2,3,4,7,8-Hexachlorodibenzo-p-dioxin (HxCDD) 0.1 0.5 0.05
1,2,3,6,7,8-Hexachlorodibenzo-p-dioxin (HxCDD) 0.1 0.1 0.01
1,2,3,7,8,9-Hexachlorodibenzo-p-dioxin (HxCDD) 0.1 0.1 0.1
1,2,3,4,6,7,8-Heptachlorodibenzo-p-dioxin (HpCDD) 0.01 0.001 <0.001
1,2,3,4,5,6,7,8-Octachlorodibenzo-p-dioxin (OCDD) 0.0001 <0.0001 0.001
2,3,7,8-Tetrachlorodibenzofuran (TCDF) 0.1 0.05 1
1,2,3,7,8-Pentachlorodibenzofuran (PeCDF) 0.05 0.05 0.1
2,3,4,7,8-Pentachlorodibenzofuran (PeCDF) 0.5 0.5 1
1,2,3,4,7,8-Hexachlorodibenzofuran (HxCDF) 0.1 0.1 0.1
1,2,3,6,7,8-Hexachlorodibenzofuran (HxCDF) 0.1 0.1 0.1
1,2,3,7,8,9-Hexachlorodibenzofuran (HxCDF) 0.1 0.1 0.1
2,3,4,6,7,8-Hexachlorodibenzofuran (HxCDF) 0.1 0.1 0.1
1,2,3,4,6,7,8-Heptachlorodibenzofuran (HpCDF) 0.01 0.01 0.01
1,2,3,4,7,8,9-Heptachlorodibenzofuran (HpCDF) 0.01 0.01 0.01
1,2,3,4,5,6,7,8-Octachlorodibenzofuran (OCDF) 0.0001 <0.0001 0.001
3,4,4′,5-Tetrachlorobiphenyl (PCB 81) 0.0001 0.0005 0.1
3,3′,4′,4′-Tetrachlorobiphenyl (PCB 77) 0.0001 0.0001 0.05
2′,3,4,4′,5-Pentachlorobiphenyl (PCB 123) 0.0001 0.000005 0.00001
2,3′,4,4′,5-Pentachlorobiphenyl (PCB 118) 0.0001 <0.000005 0.00001
2,3,4,4′,5-Pentachlorobiphenyl (PCB 114) 0.0005 <0.000005 0.0001
2,3,3′,4,4′-Pentachlorobiphenyl (PCB 105) 0.0001 <0.000005 0.0001
3,3′,4,4′,5-Pentachlorobiphenyl (PCB 126) 0.1 0.005 0.1
2,3′,4,4′,5,5′-Hexachlorobiphenyl (PCB 167) 0.00001 <0.000005 0.00001
2,3,3′,4,4′,5-Hexachlorobiphenyl (PCB 156) 0.0005 <0.000005 0.0001
2,3,3′,4,4′,5′-Hexachlorobiphenyl (PCB 157) 0.0005 <0.000005 0.0001
3,3′,4,4′,5,5′-Hexachlorobiphenyl (PCB 169) 0.01 0.00005 0.001
2,3,3′,4,4′,5,5′-Heptachlorobiphenyl (PCB 189) 0.0001 <0.000005 0.00001
793and 8 ring positions; 10–20 or so laboratories worldwide
were proficient in this work;
1990s to 2000s
13C-isotope labeled standards of all
2,3,7,8-substituted dioxins/furans available, as well as
wide array of certified or consensus real-matrix reference
materials; reliable methods available for precise, accurate
isomer-specific determination of all 2,3,7,8-substituted
dioxins/furans at ppt to ppq concentrations in virtually any
sample matrix; most results for regulatory work reported
as “toxic equivalent quantity (TEQ)” concentrations;
coplanar PCBs began to be included in TEQ calculations;
>100 laboratories worldwide are proficient in this work;
Future focus Detection limits are low enough for most
regulatory purposes, but may need to be pushed lower for
bioaccumulation studies and determination of subtle
effects from these compounds like changes in sex ratios;
future improvements will be difficult due to ubiquitous
background levels of these compounds and potentially
interfering compounds at such low DLs; biggest chal-
lenges could be to lower the high cost and to improve the
speed of analysis; bioanalytical methods may help, but are
still of limited success after over 20 years of development;
multidimensional orthogonal methods, such as two-di-
mensional chromatography (GC×GC, LC×GC ) or tandem
mass spectrometry (MS/MS), may increase selectivity and
also reduce detection limits, allowing for an increased
number of analytes in a single analysis.
Toxicology and TEFs
Dioxin-like halogenated aromatic hydrocarbons (HAHs)
provoke an extraordinarily broad spectrum of toxic effects
in vertebrate laboratory animals. Exposure to a few
micrograms per kg body weight of the most potent
congener, 2,3,7,8-TCDD, leads to (among numerous
effects) loss of body weight, liver necrosis, immune
impairment, reproductive toxicity, teratogenesis and cancer
in many laboratory species [8–11]. A single TCDD dose of
1 μg/kg is lethal to guinea pigs. In human populations
exposed to HAHs by occupation or by industrial accident,
the reported adverse health effects include reproductive
disorders [12], developmental toxicity [13, 14], insulin
insensitivity [15] and cancer [16, 17]. However, there is
considerable controversy and uncertainty about the degree
of risk to human health from dioxin-like compounds,
particularly regarding cancer risk [18, 19]. There is no
question, however, that TCDD can cause the severe skin
disorder known as chloracne in some highly-exposed
individuals [20]; chloracne is considered to be the “hall-
mark” of human dioxin toxicity.
If we understand the mechanism by which a chemical
produces its toxic effects, we are in a better position to
assess the risk that the chemical poses to humans and to
other species. Extensive research over the past quarter-
century has demonstrated that all major toxic effects of
dioxin-like chemicals are mediated by their binding to a
soluble intracellular protein, the aryl hydrocarbon receptor
(AHR) [21–23]. The AHR’s normal function is to regulate
transcription of multiple genes that are important in
development, physiologic function and adaptive responses
to xenobiotic chemicals [24, 25]. Dioxin-like chemicals
appear to exert their toxicity by dysregulating expression of
key genes that are under control of the AH receptor [23].
Throughout most of its history, the science of toxicology
has needed to cope with the effects of only one chemical at
a time. HAHs present an unusual challenge to the
toxicologist because “real-world” HAH exposure is not
to single compounds; rather, HAH exposure involves
complex mixtures of dozens to hundreds of congeners from
the dioxins (75 possible), furans (135 possible) and PCBs
(209 possible).
The fact that dioxin-like compounds work through a
common mechanism, the AHR [10, 23], fostered develop-
ment of the “toxic equivalent factors” (TEF) approach to
assessing the toxicological potency of HAH mixtures [26].
The TEF approach is based on a proposal first made by the
Ontario Ministry of the Environment in 1984 [27]. In this
approach, 2,3,7,8-TCDD, the most potent congener, is
assigned a TEF of 1.0, and all other congeners are assigned
TEFs that reflect their toxic potency relative to that of
TCDD. For example, 2,3,7,8-tetrachlorodibenzofuran and
3,3′,4,4′,5-pentachlorobiphenyl (PCB126) each are as-
signed a TEF of 0.1, whereas octachlorodioxin has a TEF
of 0.0001, reflecting its very low toxicity compared with
that of 2,3,7,8-TCDD. The toxicity of a mixture is stated as
TEQ (TCDD equivalents) and is assumed to be equal to the
sum of the concentration of individual congeners multi-
plied by their potencies (TEFi)[ 28]:
TEQ ¼Σ PCDDi   TEFi ½  þ Σ PCDFi   TEFi ½ 
þ Σ PCBi   TEFi ½ 
Note that the TEF approach applies only to agents that
are dioxin-like in that their toxic effects are mediated by the
AHR. Noncoplanar PCBs have different mechanisms of
action and are not accommodated in the TEF approach. For
simplicity it is assumed that all dioxin-like congeners
produce toxic responses that are qualitatively the same and
that the congeners differ only in their potency to produce
these adverse effects, but this simplifying assumption
should not be viewed as being true in a literal sense. It is
true, however, that the toxic potencies of congeners within
the dioxin-like category vary over several orders of
magnitude.
By definition, in order to calculate the total TEQ of a
mixture we need to know the concentration of each dioxin-
like component in the mixture. Hence the need for sensitive
and reliable congener-specific chemical analyses. Regula-
tory decisions and risk management need to proceed even
in the absence of perfect information. The TEQ approach is
794a useful simplifying strategy to allow risk assessment to
move forward for exposures that involve complex
mixtures, but it includes several assumptions [28–30].
There are two key issues:
1. What is the proper TEF for each congener?
2. What is the predominant mode of interaction between
congeners when present in a mixture?
The first question—what is the proper TEF for a
particular congener?—has not been as straightforward as
was initially envisioned. The main difficulty is that the
estimated relative potency (REP) of congeners differs
depending on what endpoint is measured, in what tissue
and in what animal species. The relative potency estimates
that underlie TEFs are derived from highly heterogeneous
data sets [27] that require judgment and interpretation
rather than providing numbers that can simply be plugged
into an equation. The TEFs currently used in risk
assessment are not based on a single biological endpoint.
Rather, current TEFs were assigned in 1997 by an expert
panel of the World Health Organization (WHO) who took
into account multiple biochemical and toxicologic end-
points. The highest weight was given to studies done in
mammalian systems in vivo (rather than in vitro), to
chronic studies (rather than acute), and to studies that
measured a toxic outcome (rather than a biochemical
response). The relative potency estimates and resulting
TEFs derived by the WHO panel are now undergoing
refinement [27].
The second question—how do components in a complex
HAH mixture interact?—is also not easily answered. The
central premise in the equation used to calculate TEQ is
that the toxic effects of components in the mixture are
additive; i.e., that the overall toxicity of the mixture is the
sum of the concentration of each congener multiplied by its
TEF. There is experimental evidence to support the
assumption of additivity [31, 32]. However, principles of
receptor pharmacology predict that compounds which
compete for the same receptor site may antagonize each
other so that the overall response is less than additive. From
the viewpoint of risk, of course it would be desirable for the
toxicity of mixtures to be less than the sum of toxicities of
individual components. Several studies have found antag-
onism between chemicals that act at the AH receptor site
[29, 33, 34]—in other words, the standard TEQ approach
in these circumstances overestimates the toxic potency of
the mixture. It also is possible that components in a mixture
might synergize to produce a response that is greater than
that predicted by the additive model. Fortunately there is
limited evidence of such an unwanted scenario for the
toxicity of dioxin-like chemicals [35].
It is important to recognize that TEF values for some
congeners can differ by tenfold or more among different
animal species. For example, the TEF for 1,2,3,4,7,8-
hexachlorodibenzo-p-dioxin is ten-fold higher in fish than
in birds (Table 1)[ 37]. When assessing risks to wildlife
from exposure to HAH mixtures, we need to be aware that
TEF values for most HAH congeners have been rigorously
determined within only a very few nonhuman, nonrodent
species. Risk estimates may be erroneous or misleading if
TEF values from one animal species are assumed to be the
same for other species.
Congener-specific chemical assays for dioxin-like
compounds have dramatically improved in sensitivity and
reliability over the past two decades. Nonetheless, such
assays remain expensive. Therefore, economical alterna-
tives have been sought which would permit estimates of the
potential toxicity of mixtures to be made. Bioassays such as
the “chemically activated luciferase gene expression” assay
(CALUX) assess the overall biological activity of a mixture
Table 2 Regulatory methods for the analysis of dioxins, furans and DLPCBs
Method Analytes/Comments Reference
USEPA 1613 Seventeen 2,3,7,8-substituted dioxins and furans and congener group totals in water and wastewater. Uses
isotope dilution–GC–HRMS
[38]
USEPA 1668a 209 PCB congeners. 12 WHO dioxin-like PCBs by GC–HRMS, the remaining 197 by GC–MS [39]
USEPA 23 Seventeen 2,3,7,8-substituted dioxins and furans and congener group totals in incinerator stack gasses. Uses
isotope dilution–GC–HRMS
[45]
USEPA 8290
(SW-846)
Seventeen 2,3,7,8-substituted dioxins and furans and congener group totals in materials and waste. Uses
isotope dilution–GC–HRMS
[46]
ISO 18073 Equivalent to USEPA 1613, also allows GC–MS as an alternate detection method [47]
ISO 17858 Twelve WHO dioxin-like PCBs in environmental matrices by GC–HRMS [48]
EN 1948 Seventeen 2,3,7,8-substituted dioxins and furans and congener group totals in stationary sources by isotope
dilution–GC–HRMS
[49]
MOE 3418 Seventeen 2,3,7,8-substituted dioxins and furans including congener group totals and 12 WHO dioxin-like
PCBs by GC–HRMS. Uses isotope dilution–GC–HRMS
[50]
ENVCAN
1/RM/19
Seventeen 2,3,7,8-substituted dioxins and furans and congener group totals in pulp and paper effluents by
isotope dilution–GC–HRMS
[51]
JIS K0312 Seventeen 2,3,7,8-substituted dioxins and furans including congener group totals in wastewater by isotope
dilution–GC–HRMS
[52]
JIS K0311 Seventeen 2,3,7,8-substituted dioxins and furans including congener group totals in incinerator stack gasses
by isotope dilution–GC–HRMS
[53]
795and do not require knowledge of the identity or concen-
tration of individual components of that mixture. The
CALUX cell bioassay is predicated on the AHR being the
mediator of toxicity. It tests sample extracts for their ability
to increase expression of a luciferase reporter gene that is
under the control of the AH receptor and thereby provides
an index to the total equivalents of dioxin-like chemicals
(CALUX–TEQ). As with chemical assays, sample extrac-
tion and sample clean-up are critical stages in bioassays
such as CALUX. For some purposes, bioassays such as
CALUX can provide a useful complement or alternative to
congener-specific chemical assays. See Windal et al. [36]
for an excellent review of the properties and applications of
CALUX.
Modern methods of analysis
The “gold standard” for the analysis of dioxins and furans
uses classical extraction techniques such as Soxhlet [38],
liquid/liquid extraction [38], solid-phase extraction (SPE)
[40, 41], or the more recent pressurized fluid extraction
[42–44]. Once the extract has been transferred to a suitable
solvent, a three-stage (silica, alumina and carbon) open-
column clean-up is followed by GC–HRMS (employing
isotope dilution) as the analytical finish. Minor variations
on this method have been used since the late 1970s and it
continues to be the method of choice for regulatory and
legal purposes. A number of these methods are listed in
Table 2.
Overview of analytical process The generic steps of the
analytical process were listed above in the “Introduction”,
except for the objectives, and data evaluation. These are
mentioned here because of their great importance, but will
not be discussed in detail. It is important to be clear about
the objectives of dioxin/furan/DLPCBs determinations,
because there are several choices in methodology—
associated with substantially different costs—that generate
data of differing precision and accuracy [54]. For example,
for rapid on-site analysis for the purpose of directing a site
remediation project, a substantially different methodology
can be used compared to that required for legal action.
Data evaluation will also not be discussed, but the authors
would simply like to make the point that in spite of
significant advances in software and data systems, the
low-level determination of dioxins, furans and DLPCBs
still requires detailed manual examination by experienced
analysts of the raw data generated by GC–HRMS systems.
A discussion of sampling is beyond the intended scope of
this review, but it may often be the case that the
imprecision of sampling is similar to or significantly
greater than the combined imprecision of the remaining
steps of the analytical process.
Sample extraction methods See [55]. Classical extraction
techniques like liquid/liquid extraction and Soxhlet ex-
traction are described in detail in the methods listed in
Table 2 and will not be addressed in this review. A number
of alternative extraction techniques are summarized in
Table 3. Supercritical fluid extraction (SFE) uses a gas
above the critical point (the combination of temperature
and pressure where the gas has liquid-like properties
enabling enhanced extraction capability) to extract ana-
lytes from the matrix. The main advantage with SFE is that
the extracting gas can be evaporated and so solvent
disposal is not required. SFE behaves significantly
differently to classical solvent extraction and recoveries
can be reduced or enhanced. Pressurized liquid extraction
(PLE), also known as accelerated solvent extraction (ASE)
evolved from SFE. Solvents were added to SFE extrac-
tions as modifiers in order to mimic classical liquid
extractions. SFE without extraction gas and only solvent
modifier best matched classical extraction recoveries. This
led to the development of PLE. Microwave-assisted
extraction (MAE or MASE) uses closed vessels to increase
pressure and extraction efficiency. Polar solvents like
acetone or water are required to supply heat for extraction.
Sun et al. [56] reported the analysis of wet samples by
MAE, indicating that significant time was saved by the
reduced sample drying requirements.
Solid-phase extraction can significantly reduce analysis
times and solvent usage for the extraction of water and
waste water samples, even with significant particulate
loadings [40]. Particles collected on C18 extraction disks
can be extracted quantitatively without Soxhlet or PLE
extraction. Water samples have also been analyzed using
semi-permeable membrane devices (SPMD). SPMD sam-
pling is a form of passive sampling that can be used for
water, air or sediments. Namiesnik [57] has recently
reviewed passive sampling techniques in environmental
samples. Passive sampling is based on the free flow of
analytes from the sampling medium to the collecting
medium. This technique eliminates the requirement for
power, and is a composite sampling procedure that can
reduce analysis cost because of reduced sampling events
and analyte loss during shipping and storage as the analyte
is on a trapping medium. Swipe tests of biofilms on
surfaces can also be used to monitor ambient conditions,
especially after fires or from fugitive emissions.
Sample extract clean-up methods Sample preparation of
dioxin extracts is one of the most challenging in analytical
chemistry. Many coextractable and potentially interfering
compounds present in the raw extract must be removed in
order provide maximum concentration factors (10
6 to 10
8)
Table 3 Alternative extraction techniques
Matrix Technique Reference
Soil/sediment/solid PLE [42–44]
SFE [58]
MASE [59]
Aqueous SPMD, passive sampling [60, 61]
SPE [40, 41]
Air Swipe/biofilms [62]
Passive sampling [63, 64]
796to meet DLs. A number of classical adsorbents can be
used, including silica, alumina, Florisil and carbon. Most
current procedures are based on the “Dow” [65] and
“Smith-Stallings” [66] procedures. These procedures are
described in detail in the references given in Table 2
above. Disposable C18/silica SPE cartridges [67] have
been used for rapid clean-up of biological materials.
The analysis of dioxins is very costly and time-
consuming. Over the past 20 years, a number of modifica-
tions have been made to automate sample extraction and
sample extract preparation to reduce analysis times and to
attempt to reduce costs. Focant [42] has recently reviewed
the automated sample preparation of biological samples.
Multicolumn automated systems like the FMS (fluid
management system) automated Power Prep system were
developed to prepare human serum extracts, and have
subsequently been used in a number of applications,
including biota, water and food. Interchangeable cartridges
(silica, alumina, carbon) can be used in different config-
urations [68, 69]. The addition of a PLE interface preceding
the Power Prep enables the sample to be extracted and
cleaned in the same automated run. Food samples (three)
have been extracted, cleaned and analyzed in ten hours
using this system [68]. An alternate method reported by
Thal [70] used an automated gel permeation chromato-
graphic (GPC)/carbon system. The GPC removes coex-
tractables like lipids from the extract, which is then
processed on activated carbon to separate the planar from
the nonplanar compounds. This is based on a system
reported by Norstrom et al. [71]. Van Beuzekom used an
automated microwave solvent extraction system (MASE)
coupled to a liquid chromatograph for the analysis of fine
particles from fire emissions [59]. Nording [72] was able to
modify a PLE extraction cell to insert the sample matrix
above AX21 carbon packing in order to perform extraction
and clean-up in the cell as a screening method. Results
compared well with GC/HRMS confirmatory analysis.
Sample preparation schemes are developed to remove
most interferences from the sample extract. Unfortunately,
because many compounds have similar physical and
chemical properties, a considerable number of interfer-
ences often still remain in the cleaned sample extracts.
Some examples of interferences on selected DLPCBs
using a 5% phenyl column are listed below [50].
PCB congener Potential interference
PCB 81 PCB 87
PCB 77 PCB 110
PCB 123 PCB 149
PCB 126 PCBs 178 and 129
PCB 156 PCB 171
PCB 157 PCB 201
Gas chromatography columns and methods PCB inter-
ferences can be eliminated or removed physically as in
MOE Method 3418, or by analyzing extracts on multiple
columns (US EPA Method 1668). A number of analyte-
specific columns have been developed to reduce both
dioxin and PCB interferences and reduce the need for
multicolumn analysis. The standard 5% phenyl columns
exhibit multiple coelutions for PCBs (see above) and
dioxins. The Rtx-Dioxin2 [73, 74] column has very few
interfering compounds. BPX-DXN exhibits very low
bleed and enhanced separation over 5% phenyl columns
[75]. Liquid crystal columns [76, 77] provide outstanding
separation for 2,3,7,8-substituted dioxins and furans, but
suffer from high bleed and low column temperature
maximum limits.
Fast GC is accomplished by reducing inner column
diameters and phase thickness. The number of theoretical
plates per meter is increased significantly. If the phase
ratio (inner column diameters/phase thickness) remains
constant, the chromatography does not change and
separations in micobore columns can be achieved much
faster because of the shorter column lengths [78–80].
MacPherson [81] reported the use of simultaneous dual
parallel column analysis of dioxins/furans/coplanar PCBs
(Fraction A) on a 40 m DB-5 column and ortho-substituted
PCBs (Fraction B) on a 20 m DB-5 column in under
45 min. Extracts were separated using activated carbon/
silica. This combination can meet GC–HRMS QC
specifications (e.g., US EPA 1613).
Two-dimensional chromatography [82–84] has been
investigated by a number of researchers in order to solve
coelution issues from single-column analysis. A number of
column combinations have been used to solve coelutions
for dioxins and PCBs [85, 86]. GC×GC produces very
narrow peaks that can provide significantly enhanced
sensitivity, increased column capacity and reduced anal-
ysis times. It requires fast detection which pushes the
limits of HRMS capability. A number of applications have
been reported using TOFMS [85, 86], ECD [87, 88] ITMS
[89] LRMS [90] and HRMS [178] as detectors for
GC×GC. The potential for enhanced chromatographic
selectivity and reduced analysis times has created a lot of
interest in this area.
Mass spectrometry detection methods See [91, 92]. HRMS
has been the definitive detection method since the
beginning of dioxin analysis (in 1973) [7]. Many detection
techniques have been investigated [93], but none can
match the selectivity and sensitivity of HRMS [94–97].
Tandem mass spectrometry as hybrid/MS [98], triple
quadrupole MS/MS [99, 100] or ion trap MS/MS [85, 101]
have been used to analyze dioxins and furans. MS/MS is
more selective than HRMS for dioxins in most cases,
because the parent molecule loses COCl, weighing 63 amu.
No other halogenated organic has been shown to fragment in
this way. The sensitivities of MS/MS instruments are
typically less than HRMS, but with slight adjustments to
sample size and final extract volume, GC–HRMS QC
specifications can typically be achieved. Eppe [102]
achieved 5:1 signal to noise with the injection of 200 fg of
2,3,7,8-TCDD. Unfortunately, the enhanced selectivity
observed with MS/MS analysis of dioxins is not experienced
with PCBs. The loss of Cl2 from the parent molecule is not
797unique to polychlorinated compounds and typically interfer-
ing peaks can be detected in the MS/MS chromatograms of
PCBs.
Electron ionization (EI) with reduced electron energy
(∼35 eV) is the typical method of ionization used in
dioxin/DLPCB analysis. The reduced electron energy
focuses ion current towards the molecular ion, reduces the
number of fragment ions, and subsequently enhances
sensitivity. Negative ion chemical ionization (NICI or
NCI) is also a low-energy ionization technique [103],
which produces mass spectra with little fragmentation,
resulting in enhanced parent ion signals. NCI analysis of
dioxins, furans and PCBs has recently been investigated
by Chernestsova using a variety of reagent gases [104].
Detection limits for PCBs are equivalent to or lower than
for EI with a trend of increasing signal strength with
increasing degree of chlorination. Similar results were
observed for dioxins, except for 2,3,7,8-TCDD which is
up to two orders of magnitude less sensitive in NCI than
EI [105]. The molecular anion of 2,3,7,8-TCDD readily
fragments to the chloride anion. Unfortunately, many other
coextractables also fragment to the chloride anion,
significantly reducing selectivity, and as a result NCI has
not been used routinely for the analysis of dioxins and
furans.
Alternate methods of analysis Due to the challenging
sample preparation, selectivity and ultra-low detection
requirements, the cost of dioxin analysis is much higher
than any other analytical method. Researchers have been
searching for alternate low-cost methods for years.
Immunoassay [106–110] and bioassay [111–114] methods
can reduce costs by 50% or more and have been used to
analyze food samples and samples collected from
hazardous sites where very fast analysis is needed. The
relative potencies for bioassays and cross-reactivities for
immunoassay methods roughly mimic toxic equivalent
factors used in mass spectrometric methods, enabling
results to be obtained in TEQ directly. The main
disadvantages of these types of methods are the inability
to use labeled internal standards to correct for recovery
and the determination of congener profiles for source
apportionment. Spiked samples, similar to standard addi-
tion quantitative analysis, permit recoveries to be
estimated, overcoming this problem. Recent publications
have shown that bio/immuno methods compare well with
Table 4 Uncertainty of dioxin, furan and DLPCB measurements in selected matrices, reported in percent (%) [127]
Parameter CAS No. Soil N=59 Biota N=34 Water N=35 Veg N=12
2,3,7,8-TCDD 1746-01-6 20 26 19 21
1,2,3,7,8-PeCDD 40321-76-4 25 17 14 21
1,2,3,4,7,8-HxCDD 39227-28-6 15 13 18 16
1,2,3,6,7,8-HxCDD 57653-85-7 17 18 30 29
1,2,3,7,8,9-HxCDD 19408-74-3 19 21 31 24
1,2,3,4,6,7,8-HpCDD 35822-46-9 12 22 38 26
1,2,3,4,5,6,7,8-OCDD 3268-87-9 15 18 31 20
2,3,7,8-TCDF 51207-31-9 15 23 37 23
1,2,3,7,8-PeCDF 57117-41-6 15 20 32 23
2,3,4,7,8-PeCDF 57117-31-4 17 16 31 27
1,2,3,4,7,8-HxCDF 70648-26-9 13 15 29 17
1,2,3,6,7,8-HxCDF 57117-44-9 14 13 34 21
1,2,3,7,8,9-HxCDF 72918-21-9 16 13 35 22
2,3,4,6,7,8-HxCDF 60851-34-5 21 16 31 24
1,2,3,4,6,7,8-HpCDF 67562-39-4 16 13 32 19
1,2,3,4,7,8,9-HpCDF 55672-89-2 11 15 37 16
1,2,3,4,5,6,7,8-OCDF 39001-02-0 21 27 15 33
N=56 N=26 N=10
PCB 77 3,3’4,4’-TCB 32598-13-3 24 14 14
PCB 81 3,4,4’,5-TCB 70362-50-4 23 16 9
PCB 105 2,3,3,’4,4’-PeCB 32598-14-4 28 71 27
PCB 114 2,3’,4,4’,5-PeCB 74472-37-0 19 17 17
PCB 118 2,3’,4,4’,5-PeCB 31508-00-6 25 90 49
PCB 123 2’,3,4,4’,5-PeCB 65510-44-3 23 22 14
PCB 126 3,3’,4,4’,5-PeCB 57465-28-8 28 15 16
PCB 156 2,3,3’,4,4’,5-HxCB 38380-08-4 19 23 9
PCB 157 2,3,3’,4,4’,5’-HxCB 69782-90-7 32 22 10
PCB 167 2,3’,4,4’,5,5’-HxCB 52663-72-6 21 12 13
PCB 169 3,3’,4,4’,5,5’-HxCB 32774-16-6 25 15 11
PCB 189 2,3,3’,4,4’,5,5’-HpCB 39635-31-9 14 17 12
798standard GC/HRMS methods in terms of sensitivity,
selectivity and accuracy [115–118].
Most analytical laboratories are now being challenged
to analyze for multiple analyte groups, including poly-
brominated diphenyl ethers (PBDEs), polychlorinated
naphthalenes, as well as dioxins, furans and DLPCBs.
Multicomponent methods have been developed for a
variety of matrices [119–122] in order to reduce costs
accrued by multiple separate extractions, clean-up and
instrumental analyses. Analysts must exercise caution
when addingadditional analyte groups to existing methods.
Modifying methods to increase the number of analytes can
result in compromised (less than ideal) conditions for a
number of analytes, giving rise to potential interferences
and/or reduced recoveries for these analytes.
Quality control and data reporting Dioxin methods
inherently include a number of quality control standards
and samples. Isotope dilution (ID) methods are typically
used with
13C-labeled internal standards. ID standards are
added prior to extraction, allowing correction for recovery
over the multistage clean-up procedures. The isotopically
labeled standards can also act as markers for the identi-
fication of native analytes in samples. As the ID standards
are often added at concentrations 10–100 times those
expected for the analytes, the standards can act as
“carriers” to improve recoveries of analytes at ultra-trace
concentrations and can offset losses due to adsorption. The
isotopically enriched standards aid in method develop-
ment/validation, as they can be added at various stages of
the analytical process to track down problems associated
with analyte recovery or method bias.
Until recently very few reference materials were available
for method validation and performance evaluation. CRMs
for sediments [123] and biota [124, 125] are now available.
Uncertainty in analytical data is an important method
attribute. The calculation of uncertainty is carried out
using data from a number of sources, including instrument
precision, linearity, fortified matrices, MDLs, spiked
samples and interlaboratory data [126]. Uncertainties for
dioxins, furans and dioxin-like PCBs are listed in Table 4
in percent (%) [127]. Uncertainties for dioxins and furans
range between 15 and 20% for most analytes. The two
most significant errors in the analysis are the error in the
standards (±10%) quoted by the manufacturer and the
error of calibration (typically ±20%) that is accepted by
the analyst. Other errors, such as mass and volumetric
determinations, should be less than 5%. Uncertainties are
elevated for water samples over soil and biota due to the
greater amount of labware that contacts the sample and the
influence of particles on the homogeneity of the sample.
Similar levels of uncertainty are observed for dioxin-like
PCBs, except for PCB 105 and 118. These congeners are
typically present at background levels of 20 and 50 pg,
respectively, in the sample. Analyte losses from the
extraction and sample preparation steps are corrected by
the isotope dilution analytical technique and should not be
significantly greater than the error in the addition of the
surrogate internal standard.
When assessing the overall error and/or uncertainty for
determinations of dioxins and DLPCBs, two important
factors are often overlooked. First, the sampling error is
not investigated in many studies. This is very difficult to
assess properly because it requires many more analyses to
be performed, and the cost of this work is often
prohibitive. Second, a growing trend is to report results
as total TEQs, and sometimes the concentration data for
individual congeners—used to perform the TEQ calcula-
tion—may not be reported at all. Also, more than one set
of toxic factors exist, and some papers do not report which
set of factors were used or the format (e.g., ND=0,
ND=1/2) in the TEQ calculation. Baccarelli [128] has
recently reviewed the reporting of TEQ values where non-
detect values are used in the TEQ calculation. It should be
remembered that the toxic factors used are themselves
approximations, and may contribute significantly to the
degree of uncertainty in the interpretation of results.
Another unfortunate trend is that reconstructed chroma-
tograms and/or congener patterns from analyses are being
reported less and less. These patterns can be useful when
assessing possible sources of the dioxins/DLPCBs
detected.
Sources, occurrence and temporal trends in PCDD/Fs
Alcock and Jones [129] have previously reviewed the
occurrence and temporal trends in PCDD/Fs in industrial-
ized countries including Germany, the United States,
Sweden, the Netherlands and the United Kingdom. This
review covered trends in sediments, air, vegetation, soils,
sewage sludge, livestock tissue and milk, wildlife and
human tissues. The authors reported a general global
temporal trend in PCDD/F inputs to the environment;
PCDD/F contamination increased in the 1930s/1940s,
reaching a maximum in the 1960s/1970s, and subsequently
declined into the 1990s as a result of actions to reduce
emissions. There is general agreement in the temporal trend
data between European and North American studies;
however, some European studies have not determined the
post-1970 declines in PCDD/F contamination evident in
North America. The US EPA [130] estimated a 75%
decrease in PCDD/F emissions over the period 1987–1995.
Päpke [131] reported declines ranging from 50–70% for
PCDD/F levels in human adipose tissue, blood and breast
milk in Germany over the period 1980–1996.
There is also now a considerable body of literature
reporting the presence of preindustrial baseline trace levels
of PCDD/F contamination in soils and sediments prior to
the turn of the nineteenth century [132–138]. Natural
sources of PCDDs/Fs can include forest fires, volcanic
activity, and other natural combustion processes [139,
140]. Although natural formation of PCDD/Fs had been
postulated much earlier, some previous studies may have
been compromised as a result of extraneous contamination
of field samples or in the laboratory [133, 135, 136]. These
measurements are significant in determining the relevance
of natural sources vs. anthropogenic sources in order to as-
799sess requirements for further reductions in global PCDD/F
emissions. However, it is also evident that any PCDD/F
loadings from natural sources are dwarfed by contempo-
rary emissions from anthropogenic sources.
PCDD/F contamination in the North American Great
Lakes has been recently reviewed by Norstrom [141],
including occurrence, geographical distribution and tem-
poral trends in air, water, sediments, fish, seabirds,
snapping turtles and humans. Patterns and concentrations
of PCDD/Fs in sediment indicate that atmospheric inputs
dominate in Lake Superior, lower Lake Michigan and Lake
Erie. Inputs from the Saginaw River to Lake Huron, and
from the Fox River to upper Lake Michigan, are
responsible for additional PCDD/PCDF loading to these
areas beyond atmospheric deposition. Lake Ontario
continues to be heavily impacted by input of PCDD/Fs,
particularly 2,3,7,8-TeCDD, from the Niagara River
[142].
A c c o r d i n gt oA l c o c ka n dJ o n e s[ 129], studies of
sediment cores from the Great Lakes represent the bulk
ofsedimenttemporaltrenddataforPCDD/Fs(e.g.,[143]);
sediment cores are particularly useful when studying the
chronology of PCDD/F contamination (e.g., [144–147]).
North American Great Lakes sediment core and biomoni-
toring data generally show that PCDD/F contamination
peaked in most lakes in the late 1960s to early 1970s,
followedbyrapidorderofmagnitudedeclinesinthemidto
late 1970s [144, 146–148]. The downward trend leveled
off in some lakes in the 1980s, but appears to have
continued after the late 1990s, presumably in response to
remedial actions and reductions in PCDD/F emissions to
the atmosphere [141]. Pearson et al. [148] reported that
Fig. 2 Geographical distribu-
tion of United States and Cana-
dian dioxin emissions for 1996.
Reproduced with permission
from Cohen et al. [149]
800Table 5 Selected global environmental concentrations of PCDD/Fs
Matrix Region Concentration Range Reference Remarks
Air Europe <1 fg TEQ/m
3 Typical rural
Air Europe 15,000 fg TEQ/m
3 Contaminated area
Air Asia 7–1,486 fg TEQ/m
3
Air South America 3–394 fg TEQ/m
3
Freshwater Korea 0.001–1.061 pg TEQ/L
Freshwater Japan 0.012–48 pg TEQ/L 2,116 sites
Seawater Japan 0.005–3.9 pg TEQ/m
3 12 sites
Seawater Japan ND–0.4 pg TEQ/m
3 21 sites
Soil Seveso, Italy 0.91–16 pg TEQ/g
Soil Germany 1–5 pg TEQ/g [143] Rural
Soil Germany 30,000 pg TEQ/g [143] Contaminated
Soil Germany 10–30 pg TEQ/g [143] Urban
Soil The Netherlands 2.2–16 pg TEQ/g [143] Rural
Soil The Netherlands 98,000 pg TEQ/g [143] Contaminated
Soil United Kingdom <1–20 pg TEQ/g [143] Rural
Soil United Kingdom 1,585 pg TEQ/g [143] Contaminated
Soil New Zealand 0.17–1.99 pg TEQ/g [143] Rural
Soil New Zealand 260–6,670 pg TEQ/g [143] Urban
Sediments Lake Ontario 91 pg TEQ/g [165] Lakewide average
Sediments Po River 1–11 pg TEQ/g [166]
Sediments Lake Baikal 0.03 pg TEQ/g
Sediments Japan 16.1–50.7 pg TEQ/g
Sediments New Zealand 0.081–2.71 pg TEQ/g
Marine sediments North Sea 5.5–17.2 pg TEQ/g
Marine sediments Gulf of Finland 101,000 pg TEQ/g Highly contaminated
Marine sediments Catalan coast 0.4–8 pg TEQ/g [167]
Marine sediments Japan 0.012–49.3 pg TEQ/g
Vegetation Germany 0.53–1.64 pg TEQ/g Pine needles
Vegetation Austria 0.3–1.9 pg TEQ/g Spruce needles
Birds and animals India 19–24 pg/g fat [168] Eagle
Birds and animals India 150–200 pg/g fat [168] Osprey
Birds and animals India 9.2–270 pg/g fat [168] Spotted Owlet
Birds and animals India 1,300–2,700 pg dioxins/g fat [168] Spotted Owlet liver
Birds and animals India 620-1,000 pg furans/g fat [168] Spotted Owlet liver
Fish Great Lakes <1–63 pg TEQ/g [169]
Fish Great Lakes <1–59 pg TEQ/g [170] Dioxin TEQ
Fish Great Lakes <1–182 pg TEQ/g [170] PCB TEQ
Fish Finnish coast 165–329 pg TEQ/g lipid [171] Herring muscle
Fish Adriatic Sea 0.23–329 pg TEQ/g lipid [171] Mackerel>Red mullet>Anchovy
Fish Japan Sea 0.10–0.95 pg TEQ/g Cod
Marine mammals Bird Island 2 pg TEQ/g blubber [172] Fur seals
Marine mammals Canadian Arctic 2–23 pg TEQ/g ww [173] Polar bears
Marine mammals Japan Sea 0.71–13 pg TEQ/g ww Whale
Marine mammals Japan Sea 17–360 pg TEQ/g ww Whale fat
Marine mammals Australia 0.1–2.6 ng/g ww Bottlenose dolphin
Food Europe 0.3–2.5 pg TEQ/g fat [174] Milk and dairy products
Food North America 0.3–0.9 pg TEQ/g fat [174] Milk and dairy products
Food South America 0.01–2.8 pg TEQ/g fat [174] Milk and dairy products
Food Asia 0.3–1.8 pg TEQ/g fat [174] Milk and dairy products
Human milk The Netherlands 17.09–21.29 pg TEQ/g fat
Human milk Ukraine 8.38–10.16 pg TEQ/g fat
Human milk Norway 7.16–7.43 pg TEQ/g fat
Human milk Czech Republic 7.44–10.73 pg TEQ/g fat
Human milk Bulgaria 5.08–7.11 pg TEQ/g fat
801PCDD/F accumulation rates in the early 1990s ranged from
<0.03 ng cm
−2 y
−1 f o rL a k eS u p e r i o rt o0 . 3 9n gc m
−2 y
−1 for
Lake Ontario; these rates represent 30–70% of maximum
accumulation in the 1960s to 1970s. In his review, Norstrom
noted the lack of comprehensive congener-specific PCDD/F
data for Great Lakes sediment cores [141].
Cohen et al. [149] modeled atmospheric transport and
deposition of PCDD/Fs to the Great Lakes using a United
States and Canadian air emissions inventory based on data
from 5,700 point sources and 42,600 area sources (Fig. 2).
They identified municipal waste incineration, iron sinter-
ing, medical waste incineration and burning of hazardous
waste in cement kilns as the most significant sources based
on 1996 emissions data. Source areas up to 2,000 km
removed from the Great Lakes were significant contribu-
tors. Combustion sources continue to be the predominant
contributor to global ambient air levels of PCDD/Fs [150].
Subsequent long-range transport of combustion emissions
are thought to be primarily responsible for the global
ubiquity of PCDD/Fs [144, 151]. Fiedler recently reviewed
global inventories of PCDD/Fs using national air inven-
tories from 23 countries to formulate a global air flux
estimated range of 7,500–13,000 g TEQs per annum [152].
Brzuzy and Hites estimated total global deposition from the
atmosphere to land at 12,500±1,300 kg y
−1 [151]. A study
published in 2000 by Wagrowski and Hites using tree bark
and soil samples estimated global deposition from the
atmosphere to land at 2–15 t y
−1 [153].
The recent report by Fiedler also showed sources of
PCDDs/Fs in developed countries to be different from
developing countries [152]. In developed countries,
industrial activities are the primary source category, while
open-burning activities are the dominant source category in
developing countries. However, burn barrels and other
household garbage burning methods are estimated to
emerge as the greatest source of PCDD/F emissions in
North America subsequent to implementation of new
industrial air emission standards [154]. Open-burning
processes include forest fires, pre- and post-harvest burning
in agriculture, burning in landfills, and backyard burning.
High releases were also estimated from incineration of
medical waste. Emissions from municipal solid waste
incineration (MSWI) were estimated to account for 70% of
the PCDD/F burden from industrial sources in the United
Kingdom in 1995 [129]; other significant sources included
emissions from metal industries and coal combustion.
Industrial emissions account for roughly 90% of the total
inventory in the United Kingdom [155]. Other combustion
sources contributing to PCDD/F emissions in industri-
alized countries include metal reclamation, wood burning,
chemical fires, automobile exhaust, cement kilns and
cigarette smoke. Non-combustion sources include chemi-
cal production (pesticides, perchloroethylene, pentachlo-
rophenol), metal production, and pulp and paper mills.
Recent data on PCDD/F emissions for individual indus-
trialized countries has been reported for the Netherlands
[156], the United Kingdom [157], the United States [130]
and Canada [158]. A global PCDD/F emission inventory
was reported by the United Nations Environmental
Program [159]. The multimedia occurrence of PCDD/Fs
globally in industrialized countries is fairly well document-
ed; however, data are generally far less common than for
other chemicals such as PCBs and organochlorine pesti-
cides. UNEP [160] has produced a report on global trends in
persistent toxics, including PCDD/Fs. Table 5 shows
selected global data for levels of PCDD/Fs in a variety of
matrices, based on information cited in the UNEP report.
Profiles of PCDD/Fs in abiotic matrices including air,
soils, and sediments in some areas can reflect the source
emission profile. However, a confounding factor in
attributing PCDD/F contamination to specific sources can
be a contrast in profiles between source samples and
corresponding profiles in environmental sinks, e.g., soils
and sediments, due to degradation, weathering, or trans-
formation processes [161]. Eitzer and Hites observed a
“consistent and systematic change” from a combustion
source profile to a sediment profile as a result of long-range
transport and depositional processes [162]. Tysklind et al.
attributed differences in PCDD/F source profiles and air
profiles to transformation processes including photolytic
degradation or hydroxyl radical reactions [163]. Koester
and Hites reported that wet and dry deposition are
important mechanisms for scrubbing PCDD/Fs from the
atmosphere, and that these mechanisms contribute to the
predominance of OCDD in sediments [164]. Ultimately,
the PCDD/F profile in environmental samples can be
influenced by both source type and environmental
processes.
Studies of congener and homolog profiles for source
apportionment have been carried out in abiotic matrices;
biota have a tendency to accumulate primarily the 2,3,7,8-
substituted compounds due to non-2,3,7,8-substituted
Matrix Region Concentration Range Reference Remarks
Blood/serum/plasma Great Lakes 27.5 ng TEQ/L [175] Recreational fishers
Blood/serum/plasma Israel 26.6–32 ng TEQ/g fat [176]
Blood/serum/plasma A So, Vietnam 16.6–45.9 pg TEQ/g lipid [177]
Blood/serum/plasma New Zealand 12.8 pg TEQ/g serum fat [143] 1,834 samples
All citations are UNEP (2003) [160] or individual UNEP Regional Assessments unless otherwise noted. ND denotes “not detected”;
ww denotes “wet weight”
Table 5 (continued)
802congeners being metabolized [129, 161]. There are
numerous examples of studies of the variation of PCDD/F
congener and homolog profiles with source (e.g., [161,
144–147]); these studies have also illustrated how different
sources of PCDD/Fs have influenced temporal trends,
primarily according to production, use and disposal of
chlorinated organics. Principal component analysis (PCA)
of profiles of source and sink samples have also proven to
be a valuable tool for source apportionment [146, 147, 161,
163].
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